Showing results (831-840 of 1,103) with videos related to
Sort By:
Pageof 111
Current Gene Therapy|March 10, 2022
Therapeutic Potential of POU3F3, a Novel Long Non-coding RNA, Alleviates the Pathogenesis of Osteoarthritis by Regulating the miR-29a- 3p/FOXO3 AxisMingmin Shi, Menghao Sun, Cong Wang, et al.Current Gene Therapy|May 12, 2018
AAV-mediated Overexpression of IL-10 Mitigates the Inflammatory Cascade in Stimulated Equine Chondrocyte PelletsKyla F Ortved, Laila Begum, Darko Stefanovski, et al.Current Gene Therapy|November 3, 2023
Vector-Mediated Delivery of Transgenes and RNA Interference-Based Gene Silencing Sequences to Astrocytes for Disease Management: Advances and ProspectivesDeepika Yadav, Rishabha MalviyaCurrent Gene Therapy|September 15, 2023
RNA Interference and Neuromuscular Diseases: A Focus on Hereditary Transthyretin AmyloidosisMarco Ceccanti, Maurizio InghilleriCurrent Gene Therapy|September 13, 2023
Innovative Genoceuticals in Human Gene Therapy Solutions: Challenges and Safe Clinical Trials of Orphan Gene Therapy ProductsRakesh SharmaCurrent Gene Therapy|July 31, 2023
Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and TherapySonali Sundram, Neerupma Dhiman, Rishabha Malviya, et al.Current Gene Therapy|September 28, 2023
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling PathwayYaxian Ning, Xiaochun Zhou, Gouqin Wang, et al.Current Gene Therapy|September 20, 2023
Exosomal miRNAs as Next-generation Therapy Vehicles in Breast CancerPriyanka Thakur, Harshita Dahiya, Ankur Kaushal, et al.Current Gene Therapy|July 27, 2023
Role of Dietary Phytochemicals in Targeting Human miRNAs for Cancer Prevention and TreatmentYasodha Kesavan, Shushrruth Sai Srinivasan, Surajit Pathak, et al.Current Gene Therapy|July 26, 2023
SFXN3 is Associated with Poor Clinical Outcomes and Sensitivity to the Hypomethylating Therapy in Non-M3 Acute Myeloid Leukemia PatientsYuxuan Dong, Fengbo Jin, Jing Wang, et al.Pageof 111